Latest Pfizer (NYSE:PFE) News

Page 1

Page 1 of 1

Pfizer’s newer medicines gain ground as COVID-19 sales retreat

Pfizer raises 2026 guidance as newer medicines offset COVID-19 decline

Pfizer has lifted its 2026 revenue and adjusted earnings guidance after a quarter in which newer and acquired medicines grew strongly enough to offset steep declines in COVID-19 products. Overall revenue was flat, while reported net income fell 8%.

Victor Sage

4 Nov 2026